Keyphrases
Heart Failure
79%
Left Ventricular Function
49%
Percutaneous Coronary Intervention
47%
Echocardiography
44%
ST-elevation Myocardial Infarction (STEMI)
41%
Left Ventricular Ejection Fraction
39%
United States
39%
Right Coronary Artery
34%
Atrial Fibrillation
33%
Patients with Heart Failure
32%
Warfarin
28%
Aspirin
28%
Hypertension
28%
COVID-19
26%
Coronary Artery Disease
24%
Heart Rate
23%
Stent
23%
Coronary Stenting
22%
Chronic Fatigue Syndrome
22%
Acute Myocardial Infarction
22%
Fractional Flow Reserve
22%
Cardiac Sarcoidosis
22%
Cardiovascular Health Study
22%
Cardiovascular Disease
22%
COVID-19 Pandemic
22%
Confidence Interval
21%
Computed Tomography
21%
Adverse Events
20%
Left Ventricular Hypertrophy
20%
Cardiologists
19%
Adverse Cardiac Events
19%
Congestive Heart Failure
19%
Sinus Rhythm
19%
Permanent Pacemaker
17%
Cardiac Magnetic Resonance
17%
Cardiac Arrest
17%
Cardiac Function
17%
Ejection Fraction
17%
Older Adults
16%
Dobutamine Stress Echocardiography
16%
Echocardiographic
16%
Bare Metal Stent
16%
Primary Prevention
16%
Beta-blockers
16%
Myocardial Infarction
16%
Vein Graft
16%
Positron Emission Tomography
16%
Myocardial Function
15%
Drug-eluting Stent
15%
Cardiovascular Testing
15%
Darbepoetin Alfa
15%
Computational Imaging
15%
Coronavirus Impact
15%
Tolerability
15%
ST Segment Analysis
15%
Wireless Technology
15%
Aorta
15%
Heart Failure Therapy
15%
Cardiac Positron Emission Tomography
15%
Primary Percutaneous Coronary Intervention
15%
Lead-free
15%
Micra
15%
Elderly People
15%
Peak Velocity
15%
Pacemaker Implantation
15%
Imaging Modalities
15%
Left Ventricular Mass
14%
Older Men
14%
Ischemic Stroke
14%
Cardiogenic Shock
14%
Left Ventricular Dysfunction
13%
Acute Coronary Syndrome
13%
Diabetes
13%
Post-percutaneous Coronary Intervention
13%
Heart Failure Treatment
12%
Persistent Left Superior Vena Cava (PLSVC)
12%
Cardiac Computed Tomography
12%
Distal Embolization
12%
Length of Hospital Stay
12%
Beneficial Effects
12%
Wireless Networks
11%
Glycoprotein IIb/IIIa Inhibitors
11%
Patient Assessment
11%
Atherosclerotic Lesions
11%
Tricuspid Valve
11%
Secondary Prevention
11%
Procedural Volume
11%
Anemia
11%
Ultrathin Polymers
11%
Pulmonary Capillary Wedge Pressure
11%
Odds Ratio
11%
Acute Decompensated Heart Failure
11%
Clinical Outcomes
11%
Revascularization
10%
Female Sex
10%
Rest of the World
10%
Blood Pressure
10%
Fully Automated
10%
Transmitral
10%
External Surface
10%
Coronary Artery Bypass Grafting
10%
Randomized Placebo-controlled Trial
10%
Cardiac Magnetic Resonance Imaging (cMRI)
10%
Treatment Algorithm
10%
Pacemaker
10%
Placebo
9%
Shock
9%
Cardiac Index
9%
Mitral Valve Repair
9%
Intervention Time
9%
Dilatation
9%
Surgical Intervention
9%
Inferior Vena Cava
9%
Intra-aortic Balloon Pump
9%
Obesity
9%
In-hospital Outcomes
9%
Angiography
9%
Healthy Controls
9%
Interventional Cardiology
9%
Valvular Heart Disease
9%
Diastolic Dysfunction
9%
Medical Therapy
8%
Overprescription
8%
Arrhythmia
8%
Drug Delivery
8%
Renal Graft
8%
Dual Antiplatelet Therapy
8%
Stent Thrombosis
8%
Hypotension
8%
Healthy Individuals
8%
Risk Factors
8%
Cardiac Disease
8%
Stress Testing
8%
Anemia Treatment
8%
Clinical Predictors
8%
Inner-city Population
8%
In-hospital Mortality
7%
Heart Failure with Preserved Ejection Fraction (HFpEF)
7%
Midodrine
7%
Valve Repair
7%
Triple Valve
7%
Adrenergic Receptors
7%
Ventricular Hypertrophy
7%
Takotsubo Cardiomyopathy
7%
Anticoagulation Quality
7%
Arm Oedema
7%
Refractory Cases
7%
Hypereosinophilic Syndrome
7%
Global Assessment
7%
Human Trials
7%
Angiogenesis
7%
Anatomical Variants
7%
Single Ostium
7%
Cardiac Amyloidosis
7%
Endothelial Monocyte-activating polypeptide-II
7%
Symptomatic Heart Failure
7%
Porcine
7%
Expression Level
7%
SYNTAX Score
7%
Chronic Myocardial Infarction
7%
Eosinophilic Myocarditis
7%
Non-valvular Atrial Fibrillation
7%
Regional Assessment
7%
Atrial Myxoma
7%
ALCAPA
7%
Unicuspid
7%
Rare Congenital Anomalies
7%
Unicuspid Aortic Valve
7%
Pleuropericarditis
7%
Pericardial Cyst
7%
P-glycoprotein Inhibitor
7%
Heart Failure Progression
7%
Guard
7%
Sleep Deprivation
7%
Asia
7%
Vasopressin Receptor Antagonists
7%
Chordal Rupture
7%
Myocardial Iron
7%
Cardiac Support
7%
Noncardiac Surgery
7%
C-Pulse
7%
Obesity Complications
7%
Unroofed Coronary Sinus
7%
Cardiovascular Complications
7%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
7%
Hypoxia
7%
Pressure Overload
7%
Cardiovascular Morbidity
7%
Pericardial Constriction
7%
Lesion Characterization
7%
GraftMaster
7%
Paroxysmal Autonomic Instability with Dystonia
7%
Contrast Echocardiography
7%
Cytokine Expression
7%
Uremic Cardiomyopathy
7%
Chordae Tendineae
7%
Efficacy Trial
7%
Coronary Thrombosis
7%
Heart Failure Stages
7%
Traumatic Aortic Rupture
7%
Cardiomyopathy
7%
Stroke Prevention
7%
Cardiac Ejection Fraction
7%
Anticoagulation Control
7%
Aortic Counterpulsation
7%
Up-titration
7%
Coronavirus Disease (COVID)
7%
Oral Anticoagulants
7%
Therapeutic Range
7%
Initial Feasibility
7%
Safety Data
7%
Hospital Teaching Status
7%
Vasopressin
7%
QT Prolongation
7%
Cocaine-induced
7%
Nitroprusside
7%
Efficacy Comparison
7%
Arterial Thrombosis
7%
Sodium Nitroprusside
7%
Improved Outcomes
7%
Strut
7%
Multiple Myeloma
7%
Length of Stay
7%
Injector
7%
Nitric Oxide Synthase Inhibitors
7%
Intracoronary
7%
Adenosine
7%
Optimal Treatment
7%
Cerebral Cavernous Malformation
7%
Vasopressin Antagonists
7%
End-stage Liver Disease
7%
Chronotropic Response
7%
Dose-escalation Study
7%
Putative Drug Targets
7%
Outcome Costs
7%
Left Atrial Pressure
7%
Coronary System
7%
Heart Rate Reserve
7%
Pharmacokinetic Effects
7%
Safety Impact
7%
Clinical Applicability
7%
In-hospital Complications
7%
Beta-blockade
7%
Osteopontin
7%
Hemodynamic Effects
7%
First-in-man Trial
7%
Cardiac Tamponade
7%
Coronary Artery Bypass Graft Surgery
7%
Pressure Monitoring
7%
Small Vessels
7%
Non-Hodgkin Lymphoma
7%
Coronary Atherosclerosis
7%
Hospitalized Patients
7%
Unusual Cause
7%
Hypertension in African Americans
7%
Iron Deposition
7%
Exercise Effect
7%
CD34+ Cells
7%
Signet Ring Cell Adenocarcinoma
7%
Rheumatic Heart Disease
7%
Hepatitis C
7%
Population-based Cohort
7%
Cognitive Impairment
7%
Liver Transplantation
7%
Intracoronary Administration
7%
Constriction
7%
Aortic Rupture
7%
Hypertrophy
7%
Chelation Therapy
7%
Flow Augmentation
7%
Pyridostigmine
7%
Dialysis
7%
Older Women
7%
Shunt
7%
Enhanced Cancer Therapy
7%
Europe
7%
Aortic Flow
7%
Multicenter Trial
7%
Right Atrium
7%
Adrenocortical Carcinoma
7%
COVID-19 Impact
7%
Coronary Perforation
7%
Imaging Diagnosis
7%
Arteriovenous
7%
Left Atrial Appendage
7%
Pocket Infection
7%
Pocket Hematoma
7%
Hemostatic Powder
7%
Prognostic Evaluation
7%
Magnetic Resonance Angiography
7%
18F-fluorodeoxyglucose Uptake
7%
Convalescent
7%
Imaging Tomography
7%
Plasma Treatment
7%
Matched Cohort Study
7%
Myocardial Blood Flow Quantification
7%
Gadolinium
7%
Pulmonary Vein
7%
Heart Rhythm
7%
Respiratory Gating
7%
Medicine and Dentistry
Congestive Heart Failure
100%
Cardiovascular System
92%
Echocardiography
47%
COVID-19
38%
Heart Left Ventricle Ejection Fraction
35%
ST Segment Elevation Myocardial Infarction
33%
Heart Function
32%
Percutaneous Coronary Intervention
31%
Myocardial Infarction
27%
Right Coronary Artery
26%
Computer Assisted Tomography
25%
Cardiac Magnetic Resonance Imaging
25%
Coronary Stenting
24%
Atrial Fibrillation
24%
Cardiovascular Disease
24%
Acute Heart Infarction
22%
Cardiac Sarcoidosis
22%
Positron Emission Tomography
22%
Diseases
21%
Myocardial Disease
21%
Stenting
20%
Electrocardiogram
19%
Coronary Artery Disease
19%
Dobutamine
16%
Stress Echocardiography
16%
Left Ventricular Hypertrophy
16%
Hemodynamic
16%
Systolic Function
16%
ST Segment
15%
Fractional Flow Reserve
15%
Heart Left Ventricle Function
15%
Pacemaker Implantation
15%
Surgery
14%
Diabetes
14%
Major Adverse Cardiac Event
13%
Vein Graft
13%
Cardiogenic Shock
13%
Triage
13%
Ejection Fraction
13%
Mitral Valve
13%
Embolization
13%
Bleeding
13%
Persistent Left Superior Vena Cava
12%
Ischemic Heart Disease
12%
Acetylsalicylic Acid
12%
Liver Transplantation
11%
Tricuspid Valve
11%
Left Atrium
11%
Diagnosis
11%
Diastolic Function
11%
Glycoprotein IIb/IIIa Inhibitors
10%
Stent Thrombosis
10%
Primary Prevention
10%
Antiplatelet
10%
Magnetic Resonance Imaging
10%
Permanent Pacemaker
10%
Heart Arrest
10%
Liver Graft
10%
Cardioversion
10%
Hazard Ratio
10%
Ventricular Hypertrophy
9%
Intra-Aortic Balloon Pump
9%
Outpatient
9%
Counterpulsation
9%
Congenital Malformation
9%
Combination Therapy
9%
Aortic Valve
9%
Inferior Vena Cava
9%
Hemodialysis
9%
Mitral Insufficiency
9%
Heart Left Ventricle Failure
9%
Myocarditis
9%
Diastolic Dysfunction
9%
Revascularization
8%
Coronary Sinus
8%
Cardiac Computed Tomography
8%
Shock (Circulatory)
8%
Controlled Clinical Trial
8%
Secondary Prevention
8%
Brain Ischemia
8%
Fluorodeoxyglucose F 18
8%
Alcohol Consumption
8%
Beta Adrenergic Receptor Blocking Agent
8%
Infection
8%
Drug-Eluting Stent
8%
Clinical Predictor
8%
Blood Pressure
8%
Fluorodeoxyglucose
8%
Valvuloplasty
7%
Chronotropism
7%
Takotsubo Cardiomyopathy
7%
Atrial Myxoma
7%
Nitric Oxide Synthase Inhibitor
7%
Arm Edema
7%
Chorda Tendinea Rupture
7%
Hypereosinophilic Syndrome
7%
Right Atrium
7%
Coronary Artery Thrombosis
7%
Hypoxia
7%
Heart Amyloidosis
7%
Pulse Rate
7%
Glycoprotein
7%
Endothelial Monocyte Activating Polypeptide II
7%
Angiogenesis
7%
Proteasome
7%
Heart Left Ventricle Performance
7%
Pericardium Cyst
7%
Interventional Cardiology
7%
Conception
7%
Complication of Obesity
7%
Intracoronary Drug Administration
7%
Noncardiac Surgery
7%
Placebo
7%
Coronary Artery Perforation
7%
Contrast Echocardiography
7%
Aortic Rupture
7%
Pulmonary Artery
7%
Aortic Flow
7%
Beta Adrenergic Receptor Blocking
7%
Chordae Tendineae
7%
Adrenal Cortex Carcinoma
7%
Dystonia
7%
Left Coronary Artery
7%
Heart Left Atrium Pressure
7%
End Stage Liver Disease
7%
Cavernous Hemangioma
7%
QT Prolongation
7%
Multiple Myeloma
7%
Thrombosis
7%
Health Care Cost
7%
Non-Hodgkin Lymphoma
7%
Constrictive Pericarditis
7%
Chelation Therapy
7%
Hepatitis C
7%
Rheumatic Heart Disease
7%
Ligation
7%
Eosinophilic
7%
Adenocarcinoma
7%
Shunt Creation
7%
Iron
7%
Gadolinium
7%
Magnetic Resonance Angiography
7%
Hemostat
7%
Cohort Analysis
7%
Heart Rate and Rhythm
7%
Electrophysiology
7%
Heart Muscle Blood Flow
7%
Prognostic Assessment
7%
Image Quality
7%
Pulmonary Vein
7%
Hematoma
7%
Rhythm
7%
Depressive Disorder
7%
Atrioventricular Node
7%
Heart Atrium Remodeling
7%
Diabetes Mellitus
7%
Pulmonary Artery Sling
7%
Heart Left Ventricle Filling
7%
Postmenopause
7%
Dofetilide
7%
Heart Rate Variability
7%
Sinus Bradycardia
7%
Muscle Weakness
7%
Primary Percutaneous Coronary Intervention
7%
Cardiac Resynchronization Therapy
7%
Vital Capacity
7%
Obstruction
7%
Remdesivir
7%
Persistent Atrial Fibrillation
7%
Retrospective Cohort Study
7%
Dyslipidemia
7%
Triacylglycerol
7%
Maturity Onset Diabetes of the Young
7%
Surgical Risk
7%
Adverse Event
7%
Infarction
6%
Creatinine
6%
Mitral Valve Replacement
6%
Infusion
6%
Right Ventricle
6%
Kidney Graft
6%
Restenosis
6%
Clinician
6%
Transthoracic Echocardiography
6%
Electrocardiography
6%
Third-Degree Atrioventricular Block
6%
Cardiac Dysrhythmia
6%
Pulmonary Artery Occlusion Pressure
6%
Dyspnea
5%
Liver Cirrhosis
5%
Coronary Angiography
5%
Heart Muscle Perfusion
5%
Apoplexy
5%
Echography
5%
Mitral Valve Stenosis
5%
Subclavian Vein
5%
Diagnostic Accuracy
5%
Coronary Artery
5%
Cardiac Catheterization
5%
Stenosis
5%
Phosphotransferase
5%
Quantitative Coronary Angiography
5%
Aortic Stenosis
5%
Vulnerable Plaque
5%
Coronary Vein
5%
Heart Muscle Biopsy
5%
Ventricular Fibrillation
5%
Cardiopulmonary Resuscitation
5%
Radiation Exposure
5%
Heart Block
5%
Smoking
5%
Heparin
5%
Transesophageal Echocardiography
5%
Coronary Artery Bypass Graft
5%
Acute Coronary Syndrome
5%